Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AstraZeneca presents new CRTh2 modulators with utility in respiratory disorders

Jan. 20, 2004

New phase II results described for NGD-2000-1 in asthma

Jan. 20, 2004

Long-term budesonide found cost-effective in mild persistent asthma of early onset

Jan. 16, 2004

Almirall Prodesfarma identifies new H1 antagonists with good selectivity profile

Jan. 15, 2004

Interferon gamma-1b in idiopathic pulmonary fibrosis

Jan. 14, 2004

Expert panel supports the benefits of inhaled corticosteroid use in asthma

Jan. 14, 2004

New p38 kinase inhibitors in early development at BMS

Jan. 14, 2004

Two series of morpholine-based CCR3 antagonists under study at GSK

Jan. 13, 2004

BCY Lifesciences seeking partner or licensee for DCF-987

Jan. 9, 2004

Alvesco NDA submission for persistent asthma

Jan. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...